(21%) were explained by pregnancy-induced hypertension (PIH), and 756 (74%) 158
were not explained by known disorders, such as autoimmune thrombocytopenic purpura 159 or systemic lupus erythematosus [55] , yielding the new term "gestational 160 thrombocytopenia" [57] . Gestational thrombocytopenia was shown to be due to a 161 gradual decline in the platelet count during the third trimester of pregnancy [56] . 162
Reduced AT activity was seen in preeclampsia [58] . AT activity decreased even in 163 healthy women during the third trimester; AT activity decreased significantly from 164 100% ± 12% at 28 weeks of gestation to 82% ± 8% at 36 weeks of gestation in women 165 with AT activity < 91% at 36 weeks of gestation [59] ; and 1 st and 3 rd percentile AT 166 activity values were 66% and 69%, respectively, just before birth in healthy women 167 [60] . 168
169

Relationships between the decrease in the platelet count and AT activity and subsequent 170 aspartate aminotransferase (AST) elevation 171
The relation between gestational thrombocytopenia and HELLP syndrome was 172 examined in women with singleton pregnancies [61] . The frequency of perinatal AST 173 elevation (> 30 IU/L) was compared between 24 women with gestational 174 thrombocytopenia and 213 control women. The 24 women exhibited a gradual decline 175 in platelet count from 210 ± 31×10 9 /L at the beginning of pregnancy to 127 ± 24×10 9 /L 176 before delivery. AST elevation occurred more frequently in the women with gestational 177 thrombocytopenia than in the controls (21% [5/24] vs. 2.8% [6/213], respectively, P <0.001). This relationship was verified again in twin pregnancies [62] . Thus, women with 179 gestational thrombocytopenia were at higher risk of developing liver dysfunction (Fig.  180   1) . 181
In patients with liver dysfunction whose antenatal changes in AT activity were 182 documented, AT activity gradually decreased to < 65% before the development of liver 183 dysfunction [25, 36, 38,] . These cases strongly suggested that women with reduced AT 184 activity were at higher risk of developing liver dysfunction. This hypothesis was 185 verified in a longitudinal and observational study of 237 women with twin pregnancies 186
[62]. The risk of AST elevation increased as the antenatal AT activity and/or the platelet 187 count decreased and was associated more closely with AT activity than the platelet 188 count [62], yielding the new term "pregnancy-induced AT deficiency (PIATD)" [63, 64] . 189
Thus, women with PIATD were at higher risk of developing liver dysfunction (Fig. 1) multifetal pregnancies may be prone to HELLP syndrome.
The risk of AFLP was higher in twin than singleton pregnancies (Table 4) . Among 16 224 reports of 10 or more women with AFLP, 12 reports indicated a high prevalence of twin 225 pregnancies ranging from 7.1% to 28.6% (Table 4) 
Clinical features of women with PIATD with or without liver dysfunction 237
A considerable number of women with AFLP showed proteinuria in the absence of 238 hypertension [7, 19, 74] , and experienced polydipsia and pulmonary edema (Table 1) . 239 The process underlying the retention of water during pregnancy may be reversed by 246 parturition, and the excess water in the interstitial space may return into the 247 intravascular space, resulting in a drop in the hematocrit value; the excess water may be 248 then excreted as urine. Women with PIATD showed a larger and sustained decrease in 249 the hematocrit value after delivery than those without PIATD, suggesting antenatal 250 hemoconcentration and a decreased plasma volume in women with PIATD [64] . AT 251 escaped from the blood into the interstitial space [78]; six ascites samples from six 252 women with PIATD and generalized edema contained AT (mean ± SD, 4.9 ± 2.2 mg/dL; 253 range, 2.7 -8.8 mg/dL) and exhibited an AT activity level of 15.5% ± 6.0% (range, 10% 254 -24%) (reference intervals in the blood, 17.0 -25.0 mg/dL for concentration and 80% 255 -130% for activity). These findings suggested that AT activity may have reflected the 256 degree of vascular permeability and resultant shortage of circulating plasma volume, 257 explaining higher rates of pre-renal acute renal failure (Table 1) The risk of AFLP and HELLP syndrome is higher in women with symptoms such as 526 abdominal pain and polydipsia, pregnancy-induced hypertension, isolated proteinuria, 527 and/or multifetal pregnancies than in women without these characteristics. *, Repeated 528 blood test is advisable for women with either a reduced platelet count (but, not reaching 529 < 120×10 9 /L) or reduced AT activity (but, not reaching < 65% 
